{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:15:59Z","timestamp":1787739359722,"version":"build-2784847793"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11033-021-06454-2","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T18:03:50Z","timestamp":1622829830000},"page":"4953-4959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["TaqMan real time PCR for the Detection of the Gilbert\u2019s Syndrome Markers UGT1A1*28; UGT1A1*36 and UGT1A1*37"],"prefix":"10.1007","volume":"48","author":[{"given":"Valentina","family":"Dapr\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Alliaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Galliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Dini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada Lo","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Calvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialaura","family":"Archetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gavatorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-1332","authenticated-orcid":false,"given":"Massimiliano","family":"Bergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"6454_CR1","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","volume":"333","author":"PJ Bosma","year":"1995","unstructured":"Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GNJ, Jansen PLM, Oude Elferink RPJ, Chowdhury NR (1995) The genetic basis of the reduced expression of bilirubin UDPglucuronosyltransferase 1 in Gilbert\u2019s syndrome. N Engl J Med 333:1171\u20131175","journal-title":"N Engl J Med"},{"issue":"3","key":"6454_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.18821\/0869-2084-2018-63-3-186-192","volume":"63","author":"AN Volkov","year":"2018","unstructured":"Volkov AN, Khabieva SM, Smirnova EY, Larionov AV (2018) The genetic diagnostics of mutations UGT1A1 in practice of modern medicine. Klin Lab Diagn 63(3):186\u2013192. https:\/\/doi.org\/10.18821\/0869-2084-2018-63-3-186-192","journal-title":"Klin Lab Diagn"},{"key":"6454_CR3","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/hep.21361","volume":"44","author":"TO Lankisch","year":"2006","unstructured":"Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP (2006) Gilbert\u2019s disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype. Hepatology 44:1324\u20131332","journal-title":"Hepatology"},{"issue":"6","key":"6454_CR4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/bcp.13574","volume":"84","author":"P Riera","year":"2018","unstructured":"Riera P, Salazar J, Virgili AC, Tobe\u00f1a M, Sebio A, Gallano P, Barnadas A, P\u00e1ez D (2018) Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity. Br J Clin Pharmacol 84(6):1389\u20131392. https:\/\/doi.org\/10.1111\/bcp.13574","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"6454_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/0300891618811283","volume":"106","author":"A Paul\u00edk","year":"2020","unstructured":"Paul\u00edk A, Nekvindov\u00e1 J, Filip S (2020) Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine. Tumori 106(2):87\u201394. https:\/\/doi.org\/10.1177\/0300891618811283","journal-title":"Tumori"},{"key":"6454_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0168-8278(02)00359-8","volume":"38","author":"PJ Bosma","year":"2003","unstructured":"Bosma PJ (2003) Inherited disorders of bilirubin metabolism. J Hepatol 38:107\u2013117","journal-title":"J Hepatol"},{"key":"6454_CR7","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","volume":"95","author":"E Beutler","year":"1998","unstructured":"Beutler E, Gelbart T, Demina A (1998) Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95:8170\u20138174","journal-title":"Proc Natl Acad Sci USA"},{"key":"6454_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5414\/CPP42133","volume":"42","author":"C Skarke","year":"2004","unstructured":"Skarke C, Grosch S, Geisslinger G, Lotsch J (2004) Single-step identification of all length polymorphisms in the UGT1A1 gene promoter. Int J Clin Pharmacol Ther 42:133\u2013138","journal-title":"Int J Clin Pharmacol Ther"},{"key":"6454_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1373\/clinchem.2004.034694","volume":"50","author":"Y Hasegawa","year":"2004","unstructured":"Hasegawa Y, Sarashina T, Ando M, Kitagawa C, Mori A, Yoneyama M, Ando Y, Shimokata K (2004) Rapid detection of UGT1A1 gene polymorphisms by newly developed Invader assay. Clin Chem 50:1479\u20131480","journal-title":"Clin Chem"},{"key":"6454_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2144\/000112563","volume":"43","author":"J Watanabe","year":"2007","unstructured":"Watanabe J, Mitani Y, Kawai Y, Kikuchi T, Kogo Y, Oguchi-Katayama A, Kanamori H, Usui K, Itoh M, Cizdziel PE, Lezhava A, Tatsumi K, Ichikawa Y, Togo S, Shimada H, Hayashizaki Y (2007) Use of a competitive probe in assay design for genotyping of the UGT1A1*28 microsatellite polymorphism by the smart amplification process. Biotechniques 43:479\u2013484","journal-title":"Biotechniques"},{"issue":"8","key":"6454_CR11","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1111\/liv.12785","volume":"35","author":"TY Shiu","year":"2015","unstructured":"Shiu TY, Huang HH, Lin HH, Shih YL, Chu HC, Chang WK, Hsieh TY (2015) Restriction fragment length polymorphism effectively identifies exon 1 mutation of UGT1A1 gene in patients with Gilbert\u2019s syndrome. Liver Int 35(8):2050\u20132056. https:\/\/doi.org\/10.1111\/liv.12785","journal-title":"Liver Int"},{"issue":"9","key":"6454_CR12","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00432-013-1480-7","volume":"139","author":"X Cai","year":"2013","unstructured":"Cai X, Cao W, Ding H, Liu T, Zhou X, Wang M, Zhong M, Zhao Z, Xu Q, Wang L (2013) Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai. J Cancer Res Clin Oncol 139(9):1579\u20131589. https:\/\/doi.org\/10.1007\/s00432-013-1480-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"6454_CR13","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1373\/clinchem.2005.054429","volume":"51","author":"JR Harraway","year":"2005","unstructured":"Harraway JR, George PM (2005) use of fully denaturing HPLC for UGT1A1 genotyping in Gilbert syndrome. Clin Chem 51:2183\u20132185","journal-title":"Clin Chem"},{"issue":"6","key":"6454_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2353\/jmoldx.2008.080036","volume":"10","author":"U Ehmer","year":"2008","unstructured":"Ehmer U, Lankisch TO, Erichsen TJ, Kalthoff S, Freiberg N, Wehmeier M, Manns MP, Strassburg CP (2008) Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert\u2019s syndrome marker UGT1A1*28. J Mol Diagn 10(6):549\u2013552. https:\/\/doi.org\/10.2353\/jmoldx.2008.080036","journal-title":"J Mol Diagn"},{"issue":"3\u20134","key":"6454_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cca.2009.11.013","volume":"411","author":"A Minucci","year":"2010","unstructured":"Minucci A, Concolino P, Giardina B, Zuppi C, Capoluongo E (2010) Rapid UGT1A1 (TA)(n) genotyping by high resolution melting curve analysis for Gilbert\u2019s syndrome diagnosis. Clin Chim Acta 411(3\u20134):246\u2013249. https:\/\/doi.org\/10.1016\/j.cca.2009.11.013","journal-title":"Clin Chim Acta"},{"key":"6454_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cca.2013.06.023","volume":"424","author":"V Thomas","year":"2013","unstructured":"Thomas V, Mazard B, Garcia C, Lacan P, Gagnieu MC, Joly P (2013) UGT1A1 (TA)n genotyping in sickle-cell disease: high resolution melting (HRM) curve analysis or direct sequencing, what is the best way? Clin Chim Acta 424:258\u2013260. https:\/\/doi.org\/10.1016\/j.cca.2013.06.023","journal-title":"Clin Chim Acta"},{"issue":"1","key":"6454_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12920-019-0527-2","volume":"12","author":"M Gulilat","year":"2019","unstructured":"Gulilat M, Lamb T, Teft WA, Wang J, Dron JS, Robinson JF, Tirona RG, Hegele RA, Kim RB, Schwarz UI (2019) Targeted next generation sequencing as a tool for precision medicine. BMC Med Genomics 12(1):81. https:\/\/doi.org\/10.1186\/s12920-019-0527-2","journal-title":"BMC Med Genomics"},{"issue":"12","key":"6454_CR18","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/clinchem\/46.12.1939","volume":"46","author":"N von Ahsen","year":"2000","unstructured":"von Ahsen N, Oellerich M, Sch\u00fctz E (2000) DNA base bulge vs unmatched end formation in probe-based diagnostic insertion\/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR. Clin Chem 46(12):1939\u20131945","journal-title":"Clin Chem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06454-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06454-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06454-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T10:19:05Z","timestamp":1625566745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06454-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["6454"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06454-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"14 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VD and MB declare financial conflicts of interest because members of the company Biomole srl that provided UGT1A1-TATA Box Dinucleotide Repeats-PCR real time cod. BioMole-011, UGT1A1-TATA (TA)5 (cod. PC-BioMole-031), UGT1A1-TATA (TA)6 (cod. PC-BioMole-030), UGT1A1-TATA (TA)7 (cod. PC-BioMole-032) and UGT1A1-TATA (TA)8 (cod. PC-BioMole-033) free of charge. All remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines protocol, applicable regulations and guidelines governing clinical study conduct and the ethical principles that have their origin in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}